What makes a good RP?
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
In a recent blog, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) discusses possibilities (and expectations) for an effective appointment and training for the Responsible Person (RP) named on the Wholesale Distribution Authorisation (WDA).
The MHRA sees a number of "key areas" an RP and its employer should consider and which MHRA "will address in turn":
- Knowledge of GDP and the relevant regulations - this is the text book stuff.
- Industry experience - relevant GDP experience.
- Familiarity with the GDP operations of the Licence Holder - particularly challenging in a large organisation.
- Induction/primary training - role familiarity.
- Role definition and place within the organisation - sufficient seniority and influence.
- Delegation and training others - The RP is responsible for all GDP activities, even those delegated.
- Training records - RP, Licence Holder and staff.
- Continuing development for the RP - the supply chain continually presents new challenges.
Source: Quelle: MHRA Inspectorate Blog "The Responsible Person named on the WDA -Part 2: Effective Appointment and Training".
Related GMP News
12.05.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3
11.05.2026European GDP Association Developments January through April 2026
21.04.2026Implementation of GDP for Pharmaceutical Products in Hong Kong
21.04.2026China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics


